Unknown

Dataset Information

0

Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas.

ABSTRACT:

SUBMITTER: Schittenhelm J 

PROVIDER: S-EPMC8028475 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
| S-EPMC4070445 | biostudies-literature
Unknown Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas.
| S-EPMC6826741 | biostudies-literature
Unknown Lactate dehydrogenase A silencing in IDH mutant gliomas.
| S-EPMC3984548 | biostudies-literature
Unknown Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
| S-EPMC6586617 | biostudies-literature
Unknown Insulator dysfunction and oncogene activation in IDH mutant gliomas.
| S-EPMC4831574 | biostudies-literature
Unknown Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain.
| S-EPMC5689569 | biostudies-literature
Unknown From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas.
| S-EPMC8157002 | biostudies-literature
Unknown IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
| S-EPMC7458656 | biostudies-literature
Unknown CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas.
| S-EPMC7890006 | biostudies-literature
Unknown Oncogenic BRAF and KRAS mutations in endosalpingiosis.
| S-EPMC8328151 | biostudies-literature